IAC/Interactivecorp (PPLI) Stock Price Today
Global EV components market to hit $1.28 trillion by 2036, driven by battery tech and power electronics
The global electric vehicle (EV) components market is projected to grow from $486.4 billion in 2026 to $1.28 trillion by 2036, expanding at a 10.2% CAGR. Growth is fueled by rising EV adoption, advancements in battery systems, power electronics, and ...
Alternative Ballistics secures new U.S. and Abu Dhabi orders, expanding less-lethal product reach.
Alternative Ballistics Corporation announced new purchase orders from U.S. online retailer Botach and a distributor in Abu Dhabi. Botach placed an initial order for The Home Defense™, marking its first online wholesale deal and expanding U.S. distrib...
Aclarion reports 85% scan volume growth in Q3 2026 and advances CLARITY trial with strong cash position.
Aclarion, Inc. announced an 85% year-over-year increase in scan volumes for Q3 2026, contributing to a 117% growth for the first nine months of the year. The company highlighted the publication of supportive clinical data in the European Spine Journa...
Global flue gas desulfurization market to grow to $31.7B by 2031 amid stricter sulfur emission rules
The global flue gas desulfurization (FGD) system market is expected to increase from $23.6 billion in 2026 to $31.7 billion by 2031, driven by stricter sulfur dioxide emission regulations and ongoing coal power use in developing countries. Growth is ...
API 6D ball valve market to grow 5% CAGR, reaching $1.61B by 2031 driven by oil, gas, and LNG investments
The global API 6D ball valve market is projected to grow from $1.20 billion in 2025 to $1.61 billion by 2031, at a 5% compound annual growth rate. Growth is fueled by investments in oil and gas infrastructure, LNG capacity, and refining operations. N...
Single cell sequencing market to grow at 15% CAGR, reaching $1.38B in 2026, driven by genomics advances and drug discovery demand.
The global single cell sequencing market is projected to grow at a 15% CAGR through 2035, reaching an estimated value of $1.38 billion in 2026. Growth is fueled by advances in genomics, reduced sequencing costs, and increased use in drug discovery, d...
AtlasClear expands clearing business with seventh broker-dealer agreement, boosting revenue potential.
AtlasClear Holdings has signed its seventh correspondent broker-dealer agreement through its subsidiary AtlasClearing, expanding its clearing platform for smaller financial institutions and fintechs. This growth is expected to increase clearing fees,...
Alphabet remains a Buy with strong growth and 42%+ upside by 2028 despite recent cash flow dips.
Alphabet Inc. is rated a Buy due to strong long-term earnings potential driven by business verticalization and faster backlog conversion. Although recent capital expenditures have reduced free cash flow, the company is expected to achieve high return...
Strategy Inc. spends 3x more on stock buybacks than Bitcoin, shifting market dynamics.
Strategy Inc. spent $890 million on stock buybacks from mid-September to mid-October 2026, three times more than its $290 million Bitcoin purchases during the same period. The company raised its buyback cap to $3 billion, focusing on repurchasing pre...
Neurocrine Biosciences starts Phase 2 trial of NBI-1117567 for mild to moderate Alzheimer's cognitive impairment
Neurocrine Biosciences has launched a Phase 2 clinical trial for NBI-1117567 (NBI-'567), an oral drug targeting muscarinic receptors to improve cognition in adults with mild to moderate Alzheimer's disease. The study will test the drug's efficacy and...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.